Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report—Part III

Published:2010-01 Issue:1 Volume:13 Page:14-17
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Mansley Edward C.,Carroll Norman V.,Chen Kristina S.,Shah Nilay D.,Piech Catherine Tak,Hay Joel W.,Smeeding James

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference19 articles.

1. The Economics of Health and Health Care;Folland,2007

2. The Managed Care Manual;Nash,1997

3. Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms,2003

4. Prescription Drug Pricing in the Private Sector;Congressional Budget Office,2007

5. AMCP Guide to Pharmaceutical Payment Methods;AMCP Task Force on Drug Payment Methodologies,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States;Value in Health;2024-02

2. Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn’s Disease in Remission on Infliximab and Azathioprine;Digestive Diseases and Sciences;2022-12-13

3. Cost-effectiveness of Implementing Smoking Cessation Interventions for Patients With Cancer;JAMA Network Open;2022-06-09

4. Branded Price Variation in the United States Drug Market, 2010 to 2019;Value in Health;2021-09

5. Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US;Journal of Medical Economics;2019-01-04